The founding member of a newly identified family of Ser/Thr kinases, DAPK (Death-Associated Protein Kinase), shares functions with other members of the family that are related to cell death as well as significant homology in their catalytic domains. An impressive body of literature has been written about the function, regulation, and relationship to disease of the kinase family as a result of the discovery that DAPk is a tumor suppressor gene, whose expression is lost in a variety of tumor types. The DAPk family has been suggested to serve purposes aside from cell death and has been connected to a number of signaling pathways related to cell death.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V76002 | CK156 | 2910938-59-7 | CK156 is a selective death-associated protein kinase (DAPK) inhibitor. |
|
V77106 | DAPK Substrate Peptide TFA | DAPK Substrate Peptide TFA is a synthetic death-associated protein kinase (DAPK) peptide substrate with a Km of 9 μM. | |
|
V116029 | DAPK1 ligand-1 | 3057532-78-9 | DAPK1 ligand-1 is a PROTAC target protein ligand that can be used to synthesize PROTACs, such as PROTAC DAPK1 degrader-1. |
|
V116489 | DRAK1/2-IN-2 | DRAK1/2-IN-2 (compound Y17) is a DRAK1/2 inhibitor with an IC50 value of 353.2 nM against DRAK2 and 507.4 nM against DRAK1. | |
|
V115808 | PROTAC DAPK1 Degrader-1 | 3063030-38-3 | PROTAC DAPK1 Degrader-1 (compound CP1) is a DAPK1 PROTAC degrader with a half-lethal concentration (DC50) of 119.6 nM. |
|
V15912 | TC-DAPK 6 | 315694-89-4 | TC-DAPK 6 is a novel, potent, ATP-competitive, and highly selective death-associated protein kinase (DAPK) inhibitor withIC50of 69 and 225 nM against DAPK1 and DAPK3, respectively, with 10 μM ATP. |
|
V119591 | UNC9750 | 2967648-29-7 | UNC9750 is an inositol polykinase (IPMK) inhibitor with IC50 values of 31.6 nM for IPMK and 374 nM for IP6K2. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
